Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa - Wikidata - awgldk - TriplyDB

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa

http://www.wikidata.org/entity/Q34111234

about

Reasons why West Africa continues to be a hotbed for hepatocellular carcinoma Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges.Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections.The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.Hepatitis B Virus Infection in Tanzania: Current Status and Challenges.A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action

P2860

Q26772209-96E51A02-AD93-46EE-A89B-D9F3349AB99B Q28488149-363E4631-A033-4491-B5B6-9DAD9BAF7CB9 Q33734612-1B82E12C-D9BC-4E9A-8B76-F095B837D271 Q33797424-0AF3388D-66BE-4B07-97B4-ECFF266BB6CE Q36699205-3E7165D2-14B5-4E96-969A-CBCC46A5B79C Q36821936-D885329C-D951-463F-804D-BB9E362FA283 Q38296047-F439CDCF-BCDE-4EEF-8A3A-76BEFD58AD90 Q40648759-8929D9D6-2E12-4767-B0BD-D9B9ADFA86DF Q47242836-C1AEF1DD-6847-4760-90EC-40FD5FCBAAC5 Q52318586-060FB502-FDF0-405C-9C4F-E63EE1A33B93 Q56669408-9993D51F-B7AF-4E70-80F4-9A33F6CDC076

P2860

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa

http://www.wikidata.org/entity/Q34111234

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@ast

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@en

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@nl

type

label

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@ast

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@en

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@nl

prefLabel

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@ast

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@en

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@nl

P1433

Q34111234-C057FC3E-7578-4B5E-90A8-CB0EA7505A7F

P1476

Q34111234-C2A88A0C-554E-453A-856E-E24026431C1D

P2093

Q34111234-059DC79A-2F46-4FA6-A2BF-01E16B5ED6E8

Q34111234-12CF1244-EF9D-48B4-B842-0B11C084121E

Q34111234-1E4BF7A4-3B2A-4B54-9A77-0C074B953E32

Q34111234-2FA9731D-45C3-4A8B-8DE5-FC02C2D0EC1B

Q34111234-3F301A91-2139-4324-925A-284918783C56

Q34111234-65640D32-5372-4657-B686-106EA84BBBAF

Q34111234-7CE19E92-77B4-40C3-9F3E-675C999FAEA9

Q34111234-95BBBCC5-BF8E-4EA3-8BF4-A57F263B672E

Q34111234-E9A98389-45C1-428F-ACE1-B8E0541A58DA

P2860

Q34111234-112F5D1C-A07C-47E1-90D3-8FC220AD9D1A

Q34111234-1BBFA6AE-64BC-4C22-8C57-38600FBEA41A

Q34111234-321A30D8-9350-4A58-B06A-11A7D69CF516

Q34111234-3F82572A-2190-460F-859E-501D47F03DCC

Q34111234-406BE20A-FAC1-4D0B-839A-57598F28F24E

Q34111234-431F357A-2AD3-42E1-894E-B1F4A4979A82

Q34111234-61CAD83B-181A-4E36-B8BC-1C366D844004

Q34111234-6216E019-3530-4128-88CD-463518D0F7C7

Q34111234-62373DB2-8831-4D93-9347-EDB2CF5686C4

Q34111234-62E35830-F975-4EC0-9098-12F9719523D9

P2888

Q34111234-1889FCB1-586D-49DE-9B8A-BD25303E00B6

P304

Q34111234-5A06F7A5-E3A4-4F72-B18F-E0EF9BF95F99

P31

Q34111234-70C57340-9B5D-4F75-BB1E-C042CE161AA6

P356

Q34111234-85480A3F-12B2-4E13-9C56-96D1BC140B21

P478

Q34111234-ECBA3A1B-0026-468D-A2E6-A2504DBD8732

P50

Q34111234-0F02840A-0790-42A6-B083-3EBA6FE24E81

Q34111234-24C17589-8110-49B8-9746-D659BCE174B4

Q34111234-745B8FDE-154A-424B-B35B-801D185E8F73

P577

Q34111234-A51396D8-686F-41A3-97FF-170C544B33C5

P5875

Q34111234-E6B5B52E-B1C5-4A9D-A568-FB24153DAC46

P6179

Q34111234-5497B6EC-9339-49B6-90F8-DA7F98AC9D93

P698

Q34111234-F6BD991A-D6FE-4DA8-8D2E-B96890EF6AFA

P921

Q34111234-72E7AD59-6EF7-4B9B-9F06-75E033FC5215

Q34111234-CC55DE79-00B9-4AEC-BE1F-A153ADD87FFA

P932

Q34111234-D55C27AE-2AEF-44B1-BB24-AF09132DBC44

P356

1756-0500-4-561

P1433

BMC Research Notes

P1476

Emergence of HBV resistance to ...... nts in The Gambia, West Africa

@en

P2093

Abraham Alabi

http://www.w3.org/2001/XMLSchema#string

Assan Jaye

http://www.w3.org/2001/XMLSchema#string

Balint Stewart

http://www.w3.org/2001/XMLSchema#string

Hilton Whittle

http://www.w3.org/2001/XMLSchema#string

Ingrid Peterson

http://www.w3.org/2001/XMLSchema#string

Kevin Peterson

http://www.w3.org/2001/XMLSchema#string

Maimuna Mendy

http://www.w3.org/2001/XMLSchema#string

Ramu Sarge-Njie

http://www.w3.org/2001/XMLSchema#string

Sarah Rowland-Jones

http://www.w3.org/2001/XMLSchema#string

P2860

The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance

Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy.

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia.

Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia.

Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion.

Current treatment of HIV/hepatitis B virus coinfection.

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

HIV-2: the forgotten AIDS virus.

P2888

1756-0500-4-561

P304

561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1756-0500-4-561

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Modou L Jobarteh

Thushan I de Silva

P577

2011-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51921849

http://www.w3.org/2001/XMLSchema#string

P6179

1045395788

http://www.w3.org/2001/XMLSchema#string

P698

22195774

http://www.w3.org/2001/XMLSchema#string

P921

Afelika ya Lumonso

P932

3292846

http://www.w3.org/2001/XMLSchema#string